𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glucocorticoid-induced cortical bone loss is mediated by osteoblast-controlled activation of bone resorption

✍ Scribed by M. Herrmann; H. Henneicke; J. Street; J. Modzelewski; R. Kalak; F. Buttgereit; C.R. Dunstan; H. Zhou; M.J. Seibel


Book ID
116321174
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
163 KB
Volume
44
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


IL-1- and TNF-induced bone resorption is
✍ Sanjay Kumar; Bartholomew J. Votta; David J. Rieman; Alison M. Badger; Maxine Go πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 241 KB

We have previously shown that p38 mitogen-activated protein kinase (MAPK) inhibitors, which block the production and action of inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), are effective in models of bone and cartilage degradation. To further investigate the ro

Bone loss induced by Runx2 Over-expressi
✍ Corinne Schiltz; Christophe Prouillet; Caroline Marty; Didier Merciris; Corinne πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 627 KB

## Abstract The Runx2 gene is essential for osteoblast differentiation and function. In vivo over‐expression of Runx2 in osteoblasts increases bone resorption, and blocks terminal osteoblast differentiation. Several lines of evidence suggest that osteoblastic matrix metalloproteinases (MMPs) could